Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
1996-1-18
|
pubmed:abstractText |
The effects of substance P, substance P-(1-7) and substance P-(5-11) on endogenous dopamine outflow in rat striatal slices were investigated. The dose-response curves (0.01 nM to 10 microM) were bell-shaped, with significant increases at 0.1 and 1 nM but with no effect at higher concentrations. The tachykinin NK1 receptor agonist, [Sar9,Met(O2)11]substance P, significantly increased dopamine outflow at 10 and 100 nM. The effects of substance P or substance P-(5-11) and 25 mM KCl were additive. A negative interaction was observed with substance P-(1-7) and K+. The increase in dopamine outflow elicited by 1 nM substance P and substance P-(5-11) was reversed by the tachykinin NK1 receptor antagonist WIN 51,708 (17 beta-hydroxy-17 alpha-ethynyl-5 alpha-androstano[3,2-b]pyrimido[1,2- alpha]benzimidazole) (25 and 250 nM), whereas only partial reversal was observed for the effect of substance P-(1-7). These results show that substance P fragments locally modulate striatal dopamine outflow and the mechanisms underlying this modulation may differ between N- and C-terminal fragments.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androstanes,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurokinin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Substance P,
http://linkedlifedata.com/resource/pubmed/chemical/WIN 51708,
http://linkedlifedata.com/resource/pubmed/chemical/substance P, Sar(9)-Met(O2)(11)-,
http://linkedlifedata.com/resource/pubmed/chemical/substance P (1-7),
http://linkedlifedata.com/resource/pubmed/chemical/substance P (5-11)
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
282
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-33
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:7498281-Androstanes,
pubmed-meshheading:7498281-Animals,
pubmed-meshheading:7498281-Benzimidazoles,
pubmed-meshheading:7498281-Corpus Striatum,
pubmed-meshheading:7498281-Dopamine,
pubmed-meshheading:7498281-Male,
pubmed-meshheading:7498281-Peptide Fragments,
pubmed-meshheading:7498281-Potassium,
pubmed-meshheading:7498281-Rats,
pubmed-meshheading:7498281-Rats, Wistar,
pubmed-meshheading:7498281-Receptors, Neurokinin-1,
pubmed-meshheading:7498281-Substance P
|
pubmed:year |
1995
|
pubmed:articleTitle |
Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum.
|
pubmed:affiliation |
Department of Pharmacology, Faculty of Medical Sciences, Queen Mary and Westfield College, London, UK.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|